Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ

$16.52

$-0.21

(-1.23%)

After-Hours

Aurinia Pharmaceuticals Inc. (AUPH) Live Price Chart

Last updated: ⁦2026-10-16 21:57:00⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Aurinia Pharmaceuticals Inc. (AUPH) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $16.53, with a market capitalization of $2.21B and a P/E ratio of 7.09. Over the past 52 weeks, its price has ranged from $11.30 to $19.25. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$2.21B
Open	$16.81
Day's High	$33.97
Day's Low	$1.41
Previous Close	$16.73
Volume	582.51K
Average Volume	976.48K
P/E Ratio	7.09
52-Week High	$19.25
52-Week Low	$11.30
Dividend Yield	--
Earnings Date	--

Aurinia Pharmaceuticals Inc. (AUPH) After-Hours Stock Price

Aurinia Pharmaceuticals Inc. (AUPH) is trading at $16.65 in after-hours trading as of 2026-10-16 21:52:00, down 0.46% ($0.08) from the regular-session close of $16.73.

After-hours trading shows how investors are pricing AUPH after the regular session closes. The current after-hours price is near the regular-session close, indicating cautious after-hours sentiment.

Aurinia Pharmaceuticals Inc. (AUPH) 7-Day Stock Price Change

Over the past seven days, Aurinia Pharmaceuticals Inc. (AUPH) moved from $16.01 to $16.53, representing a gain of 3.22% ($0.51).

The stock traded between $15.50 and $17.30 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 916.57 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

AUPH 52-Week Price Position

Position in Range: 65.7%

52W Low$11.30

52W High$19.25

AUPH is currently trading at $16.53, placing it 65.7% of the way from its 52-week low of $11.30 to its 52-week high of $19.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Aurinia Pharmaceuticals Inc. (AUPH)?

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Aurinia Pharmaceuticals Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	128
Exchange	NASDAQ
Company Website	https://www.auriniapharma.com

How to Buy Aurinia Pharmaceuticals Inc. (AUPH) Stock on MEXC

Eligible investors can buy real shares of Aurinia Pharmaceuticals Inc. (AUPH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AUPH and Place Your Order

Open the RealStocks trading page and search for AUPH. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Aurinia Pharmaceuticals Inc. (AUPH) stock price today?

Aurinia Pharmaceuticals Inc. (AUPH) is currently trading at $ 16.53, down 1.23% ($0.21) from the previous close of $ 16.73. Intraday prices update in real time during regular trading hours.

2.Is AUPH stock going up or down today?

As of 2026-10-16 21:52:00, AUPH is trading at $ 16.53, down 1.23% ($0.21) from its previous close of $ 16.73. The stock has traded between $ 1.41 and $ 33.97 during today’s regular session. Past price movements do not guarantee future results.

3.What is AUPH pre-market price?

As of 2026-10-16 21:52:00, AUPH is trading at $ 16.65 in pre-market trading, down 0.48% ($0.08) from the previous close of $ 16.73. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AUPH after-hours price?

As of 2026-10-16 21:52:00, AUPH is trading at $ 16.65 in after-hours trading, down 0.46% ($0.08) from the regular-session close of $ 16.73. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AUPH stock trading now?

AUPH trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AUPH sit relative to its 52-week high and low?

Over the past 52 weeks, AUPH has traded between a low of $ 11.30 and a high of $ 19.25. At $ 16.53, the stock is positioned 65.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Aurinia Pharmaceuticals Inc. in?

Aurinia Pharmaceuticals Inc. (AUPH) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Aurinia Pharmaceuticals Inc.'s market capitalization and where is it listed?

Aurinia Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalization of $ 2.21B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AUPH valued in terms of P/E ratio and EPS?

AUPH trades at a P/E ratio of 7.09, based on trailing-twelve-month EPS of $ 2.36. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Aurinia Pharmaceuticals Inc. pay a dividend?

Aurinia Pharmaceuticals Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.